NASDAQ · Financial Statements
Traws Pharma, Inc. (TRAW) Financial Statements
$0.45
NASDAQ: TRAW
Market Cap $6.78M
Overview Financials Dividend Traws Pharma, Inc. most recently reported annual revenue of $3.0M, net profit of $9.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $3.0M Operating Profit $-16.0M $-20.0M $-20.0M $-49.0M $-18.0M Net Profit $-16.0M $-19.0M $-19.0M $-55.0M $9.0M EPS $-24.01 $-22.68 $-22.57 $-35.21 $0.82 Op Margin -7299.1% -8684.5% -8981.4% -21835.4% -640.7%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $55.0M $39.0M $23.0M $25.0M $11.0M Total Liabilities $9.0M $11.0M $12.0M $57.0M $11.0M Cash $55.0M $39.0M $21.0M $21.0M $4.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-19.0M $-16.0M $-18.0M $-30.0M $-18.0M Investing Cash Flow $0 $0 $0 $-4.0M $-5.0M Financing Cash Flow $1.0M $0 $0 $0 $-2.0M Net Cash Flow $36.0M $-16.0M $-18.0M $1.0M $-18.0M Free Cash Flow $-19.0M $-16.0M $-18.0M $-30.0M $-21.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -0.29 FCF Yield -73.13% Quick Ratio 0.43 Interest Coverage 0.00 Return 1Y -55.78% Return 3Y -97.64% Return 5Y -99.49%
Screens featuring this stock